ArticleThe Journal of pharmacology and experimental therapeutics2011

The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.

Anna E Maciag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.